Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study
Authors contributions Designed and conducted the study, performed data acquisition and analysis, and wrote the manuscript: Zhang W, Xue J Collected and managed data: Wang J, Ni D, Zhou W Performed data management: Wang B, Shi J Conceived and designed the study, conducted it, interpreted the data, and revised the manuscript: Wang A All the authors have read and approved the final version of this manuscript
Most of these symptoms are transient and will resolve as your body reaches a new steady state on the adjusted schedule
the same membrane was probed using an anti-HA antibody to assess the efficiency of the immunoprecipitation procedure
This increased adhesion promotes greater uptake of quercetin by intestinal cells and enhances its antioxidant activity
In the TOGETHER-PsA trial, Merola and colleagues assessed the efficacy and safety of combination therapy with ixekizumab (Taltz, Eli Lilly) plus tirzepatide (Zepbound, Eli Lilly), compared with ixekizumab alone in a cohort of 271 adults with active PsA and overweight or obesity, aligned with the on-label dosing of both interventions
